At OptiLive we have started with a focus on atherosclerotic cardiovascular disease (ASCVD), which remains the most common cause of death in the country. ASCVD kills about 2300 people every day in the United States, according to the Center for Disease Control. And a very large proportion of these victims had no idea they had a problem before suffering sudden death.

We are pleased to offer our patients access to a non-invasive approach to diagnosing ASCVD early, when lifestyle modifications and medication can have a huge impact on outcomes. The approach is based on a Coronary Computed Tomography Angiogram (CCTA) and image analysis using an artificial intelligence method provided by Cleerly Health. At the heart of the Cleerly innovation is a digital care pathway, a closed-loop, step-by-step approach to facilitate early diagnosis, informed decision-making, and personalized treatment and tracking of coronary heart disease.

It is important to note that we believe in the importance of primary care for patients, and our providers are committed to collaborate with your existing healthcare provider team. We share all our reports with our patients and encourage them to be shared with existing providers, and we are also happy to assist with referrals to specialists for follow up whenever indicated.

New medical technologies continue to evolve at rapid rates that are difficult for patients to track and comprehend. At OptiLive we look forward to the opportunity to serve as a trusted advisor in this exciting environment, helping people achieve their potential for a long and healthy lifespan.